RECRUITINGOBSERVATIONAL
Wearable Devices Faciliate the Management of AMI Patients
Wearable Device for Characterizing AMI Patients After Primary PCI and Predicting the Clinical Outcomes
About This Trial
The study will explore the use of wearable technology to consistently monitor patients with acute myocardial infarction (AMI) receiving primary percutaneous coronary intervention (PCI). Parameters such as heart rate, sleep time, physical activity, and blood pressure will be collected and analyzed to characterize the patients and predict clinical outcomes.
Who May Be Eligible (Plain English)
Who May Qualify:
- Aged 18-75 years old
- Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
- Half male and half female
- Undergo CAG and PCI treatment;
- Written willing to sign a consent form.
Who Should NOT Join This Trial:
- People under the age of 18 years old;
- Patients who are pregnant/breastfeeding;
- Patients who are allergic to the metallic or plastic components of the wearable devices
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Aged 18-75 years old
* Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
* Half male and half female
* Undergo CAG and PCI treatment;
* Written informed consent.
Exclusion Criteria:
* People under the age of 18 years old;
* Patients who are pregnant/breastfeeding;
* Patients who are allergic to the metallic or plastic components of the wearable devices
Locations (1)
Renji Hospital
Shanghai, China